0001437749-23-032809.txt : 20231121 0001437749-23-032809.hdr.sgml : 20231121 20231121201135 ACCESSION NUMBER: 0001437749-23-032809 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231117 FILED AS OF DATE: 20231121 DATE AS OF CHANGE: 20231121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Demopulos Gregory A MD CENTRAL INDEX KEY: 0001472160 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34475 FILM NUMBER: 231429718 MAIL ADDRESS: STREET 1: 201 ELLIOTT AVENUE WEST CITY: SEATTLE STATE: WA ZIP: 98119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OMEROS CORP CENTRAL INDEX KEY: 0001285819 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911663741 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 ELLIOTT AVENUE WEST CITY: SEATTLE STATE: WA ZIP: 98119 BUSINESS PHONE: 206-676-5000 MAIL ADDRESS: STREET 1: 201 ELLIOTT AVENUE WEST CITY: SEATTLE STATE: WA ZIP: 98119 4 1 rdgdoc.xml FORM 4 X0508 4 2023-11-17 0001285819 OMEROS CORP OMER 0001472160 Demopulos Gregory A MD 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 1 Chairman, CEO & President 0 Common Stock 2023-11-17 4 P 0 15000 1.68 A 123945 I By Spouse Common Stock 2026986 D The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and nothing in this report shall be deemed an admission that the reporting person is the beneficial owner of such securities under Section 16 of the Securities Exchange Act of 1934 or for any other purpose. /s/ Peter B. Cancelmo, Attorney-in-Fact 2023-11-21